Principal Financial Group Inc. Has $45.31 Million Stock Position in Select Medical Holdings Co. (NYSE:SEM)

Principal Financial Group Inc. grew its holdings in Select Medical Holdings Co. (NYSE:SEM - Free Report) by 1.9% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 2,403,508 shares of the health services provider's stock after purchasing an additional 45,685 shares during the period. Principal Financial Group Inc. owned about 1.86% of Select Medical worth $45,310,000 as of its most recent SEC filing.

A number of other hedge funds have also made changes to their positions in the stock. Geode Capital Management LLC lifted its position in Select Medical by 2.0% in the 3rd quarter. Geode Capital Management LLC now owns 2,442,321 shares of the health services provider's stock worth $85,180,000 after buying an additional 46,880 shares in the last quarter. Point72 Asset Management L.P. increased its position in Select Medical by 144.2% in the 3rd quarter. Point72 Asset Management L.P. now owns 2,059,791 shares of the health services provider's stock worth $71,825,000 after purchasing an additional 1,216,263 shares during the last quarter. Charles Schwab Investment Management Inc. raised its stake in shares of Select Medical by 1.5% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 1,646,320 shares of the health services provider's stock worth $57,407,000 after purchasing an additional 24,439 shares in the last quarter. Victory Capital Management Inc. lifted its holdings in shares of Select Medical by 0.6% during the 3rd quarter. Victory Capital Management Inc. now owns 1,181,078 shares of the health services provider's stock valued at $41,184,000 after buying an additional 7,372 shares during the last quarter. Finally, JPMorgan Chase & Co. grew its stake in shares of Select Medical by 9.7% in the 3rd quarter. JPMorgan Chase & Co. now owns 416,299 shares of the health services provider's stock valued at $14,516,000 after buying an additional 36,905 shares in the last quarter. 89.48% of the stock is owned by hedge funds and other institutional investors.

Select Medical Price Performance

Shares of NYSE:SEM traded up $0.83 during midday trading on Monday, reaching $18.51. The company's stock had a trading volume of 1,225,852 shares, compared to its average volume of 871,570. The business's fifty day simple moving average is $19.07 and its 200-day simple moving average is $27.81. The company has a market capitalization of $2.40 billion, a P/E ratio of 11.22, a P/E/G ratio of 0.64 and a beta of 1.45. The company has a debt-to-equity ratio of 1.37, a current ratio of 1.13 and a quick ratio of 1.13. Select Medical Holdings Co. has a fifty-two week low of $16.20 and a fifty-two week high of $40.98.

Select Medical (NYSE:SEM - Get Free Report) last posted its quarterly earnings data on Thursday, February 20th. The health services provider reported $0.18 earnings per share for the quarter, missing the consensus estimate of $0.29 by ($0.11). The company had revenue of $1.31 billion during the quarter, compared to the consensus estimate of $1.50 billion. Select Medical had a return on equity of 14.04% and a net margin of 3.23%. As a group, equities research analysts expect that Select Medical Holdings Co. will post 1.17 EPS for the current fiscal year.

Select Medical Cuts Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, March 13th. Investors of record on Monday, March 3rd will be given a $0.0625 dividend. The ex-dividend date of this dividend is Monday, March 3rd. This represents a $0.25 dividend on an annualized basis and a yield of 1.35%. Select Medical's payout ratio is 30.30%.

Wall Street Analyst Weigh In

Several research analysts have recently commented on SEM shares. Royal Bank of Canada dropped their price target on shares of Select Medical from $47.00 to $23.00 and set an "outperform" rating on the stock in a research note on Monday. Benchmark upgraded Select Medical from a "hold" rating to a "buy" rating and set a $23.00 price target for the company in a research note on Monday. UBS Group reduced their target price on Select Medical from $40.00 to $21.00 and set a "neutral" rating for the company in a report on Friday, January 3rd. Finally, StockNews.com raised shares of Select Medical from a "hold" rating to a "buy" rating in a research report on Friday. One investment analyst has rated the stock with a hold rating and four have given a buy rating to the company's stock. According to MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus price target of $27.25.

Insiders Place Their Bets

In related news, Director Marilyn B. Tavenner sold 32,000 shares of Select Medical stock in a transaction on Tuesday, November 26th. The stock was sold at an average price of $21.09, for a total transaction of $674,880.00. Following the completion of the sale, the director now directly owns 22,000 shares of the company's stock, valued at $463,980. The trade was a 59.26 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, VP Robert G. Breighner, Jr. sold 4,989 shares of the stock in a transaction dated Wednesday, December 4th. The shares were sold at an average price of $19.95, for a total value of $99,530.55. Following the completion of the transaction, the vice president now directly owns 30,356 shares in the company, valued at $605,602.20. The trade was a 14.12 % decrease in their position. The disclosure for this sale can be found here. Company insiders own 19.14% of the company's stock.

About Select Medical

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.